Tel. 705-566-0005 [email protected]
  • https://www.facebook.com/MedicorResearch?ref=hl
  • https://www.instagram.com/medicorresearch/
  • https://twitter.com/MedicorResearch
  • https://www.linkedin.com/groups?gid=3726387&mostPopular=&trk=tyah&trkInfo=clickedVertical%3Agroup%2Cidx%3A2-1-3%2CtarId%3A1427739559973%2Ctas%3AMedicor+Research
Medicor Research Inc.
  • Home
  • About Us
    • WELCOME
    • OUR CULTURE
    • CORPORATE SOCIAL RESPONSIBILITIES
    • OUR TEAM
    • OUR VOLUNTEERS
  • Clinical Trials
    • RECRUITING TRIALS
    • ONGOING TRIALS
    • UPCOMING TRIALS
    • COMPLETED TRIALS
    • FUTURE TRIALS
    • REGISTER TODAY!
  • SERVICES
    • Patients
    • Physicians
      • Clinical Trials
      • Research Studies
      • Sponsors
  • Careers
  • Contact
  • REGISTER TODAY!

Services Archives

Home /

Alopecia Areata – HZNP-DAX-201

A Phase 2A, Open Label, Proof-of-Concept Trial of Daxdilimab for the Treatment of Moderate-to-Severe Alopecia Areata Register Today!

Read More

For more information contact:

 705-566-0005
 [email protected]
Medicor Research Inc. © 2015. All Rights Reserved. | Website Design by Cuch Creative | Privacy Statement